Table 2.

Univariable Regression Coefficients (Standard Errors) of Renal Parameters and Other Clinical Variables for Flow-Mediated Dilution in the Overall Study Cohort and in Subgroups Receiving and Not Receiving Antiretroviral Therapy

	Total cohort		Receiving ART		Not receiving ART
Variable	FMD β (SE)	P value	FMD β (SE)	P value	FMD β (SE)	P value
Baseline diameter, cm	−23.59 (5.31)	<.0001	−19.65 (7.22)	.009	−28.06 (7.97)	.0009
Male sex	−2.52 (0.81)	.002	−2.92 (1.01)	.006	−1.97 (1.35)	.15
NTGMD	0.14 (0.05)	.004	0.13 (0.07)	.05	0.14 (0.06)	.02
Urine PCR	−0.92 (0.97)	.34	−0.74 (1.26)	.56	−1.15 (1.53)	.45
Urine PCR >0.2 g/g	−2.11 (1.24)	.09	1.80 (1.97)	.36	−2.26 (1.37)	.18
Urine ACR	−1.40 (1.42)	.33	−0.84 (1.81)	.65	−2.23 (2.32)	.34
Urine ACR >30 mg/g	−0.48 (1.21)	.69	−1.50 (1.64)	.36	0.55 (1.79)	.76
CrCl, mL/min	0.001 (0.01)	.90	0.02 (0.01)	.20	−0.01 (0.01)	.32
eGFR, mL/min/1.732	−0.01 (0.01)	.36	−0.01 (0.01)	.58	−0.02 (0.02)	.48

Abbreviations: ACR, albumin-creatinine ratio; ART, antiretroviral therapy; CrCl, creatinine clearance; eGFR, estimated glomerular filtration rate; FMD, flow-mediated dilution; NTGMD, nitroglycerin-mediated dilution; PCR, protein-creatinine ratio; SE, standard error.